Massimo Gennarelli
Biographic Data
| ID | 4353120 |
|---|---|
| NAME | Massimo Gennarelli |
| GIVEN NAMES | Massimo |
| FAMILY NAME | Gennarelli |
| SIGNATURE | GENNARELLI M |
| AFFILIATIONS | Centro San Giovanni di Dio Fatebenefratelli |
| ORCID | 0000-0003-4192-945X |
| VERIFIED | Yes |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 6 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1992 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Factors influencing patient decision-making on a multimodal precision medicine algorithm for depression
While patients are open to the use of a multimodal precision medicine algorithm for MDD, they emphasised the need for individualised, transparent communication and emotional support. The results highlight the importance of patient-centred communication strategies and guidelines for the ethical implementation of precision psychiatry
Attitudes towards a multimodal precision medicine algorithm for predicting treatment response in depression
Overall, participants indicated a large degree of acceptance towards the application of a multimodal precision medicine algorithm. Although limited by the hypothetical nature of the decision scenario, this study provides valuable perspectives from different stakeholders. Future research should move beyond attitudes and address further implementation hurdles that need to be overcome for the successful implementation of novel precision psychiatry a…
An integrated precision medicine approach in major depressive disorder
Major depressive disorder (MDD) is the most common psychiatric disease worldwide with a huge socio-economic impact. Pharmacotherapy represents the most common option among the first-line treatment choice; however, only about one third of patients respond to the first trial and about 30% are classified as treatment-resistant depression (TRD). TRD is associated with specific clinical features and genetic/gene expression signatures. To date, single …
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
High conservation of the trinucleotide [CTG]n repeat at the myotonic dystrophy locus in nonhuman primates
Analysis of apoB, HLADQ alpha, and D1S80 polymorphisms in the Italian population using the polymerase chain reaction
Allele and genotype frequencies of three highly polymorphic loci (apoB, HLADQ alpha, D1S80) have been determined in an Italian sample using the polymerase chain reaction (PCR) amplification and non‐radioactive detection. The allele frequencies ranged from 0.1% to 39%, with an average heterozygosity of 0.74 and a power of discrimination ranging from 0.90 to 0.98. These results are of value for forensic and genetic studies. © 1992 Wiley‐Liss, Inc
No prominent works on this page.
Analysis of apoB, HLADQ alpha, and D1S80 polymorphisms in the Italian population using the polymerase chain reaction
Allele and genotype frequencies of three highly polymorphic loci (apoB, HLADQ alpha, D1S80) have been determined in an Italian sample using the polymerase chain reaction (PCR) amplification and non‐radioactive detection. The allele frequencies ranged from 0.1% to 39%, with an average heterozygosity of 0.74 and a power of discrimination ranging from 0.90 to 0.98. These results are of value for forensic and genetic studies. © 1992 Wiley‐Liss, Inc
High conservation of the trinucleotide [CTG]n repeat at the myotonic dystrophy locus in nonhuman primates
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
An integrated precision medicine approach in major depressive disorder
Major depressive disorder (MDD) is the most common psychiatric disease worldwide with a huge socio-economic impact. Pharmacotherapy represents the most common option among the first-line treatment choice; however, only about one third of patients respond to the first trial and about 30% are classified as treatment-resistant depression (TRD). TRD is associated with specific clinical features and genetic/gene expression signatures. To date, single …
Factors influencing patient decision-making on a multimodal precision medicine algorithm for depression
While patients are open to the use of a multimodal precision medicine algorithm for MDD, they emphasised the need for individualised, transparent communication and emotional support. The results highlight the importance of patient-centred communication strategies and guidelines for the ethical implementation of precision psychiatry
Attitudes towards a multimodal precision medicine algorithm for predicting treatment response in depression
Overall, participants indicated a large degree of acceptance towards the application of a multimodal precision medicine algorithm. Although limited by the hypothetical nature of the decision scenario, this study provides valuable perspectives from different stakeholders. Future research should move beyond attitudes and address further implementation hurdles that need to be overcome for the successful implementation of novel precision psychiatry a…
Biology (4 works) · Gene (3 works) · Precision medicine (3 works) · Computer Science (2 works) · Digital Mental Health Interventions (2 works) · Evolutionary biology (2 works) · Genetics (2 works) · Medicine (2 works) · MEDLINE (2 works) · Mental Health Treatment and Access (2 works)